Promote Sponsor
verified SJR 0,51 · Q3 • database Scopus / SJR & Web of Science indexed
Human Psychopharmacology
United Kingdom · John Wiley and Sons Ltd
workspace_premium Q3 — Neurology (clinical) lock_open Open Access Unclaimed

Human Psychopharmacology

Human Psychopharmacology is a journal indexed in SJR in Neurology (clinical) and Psychiatry and Mental Health with an H index of 87. It has a price of 2040 €. It has an SJR impact factor of 0,51 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,51.

Human Psychopharmacology focuses its scope in these topics and keywords: efficacy, biloba, antidepressants, openlabel, disorder, clinical, healthy, effects, trials, review, ...

ISSN: 0885-6222
Editorial: John Wiley and Sons Ltd
Category: Neurology (clinical)
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,51 Q3
H-index 87
Tasa de Aceptación pie_chart
26% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
2.040 € Open Access
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,51

H-index

87

Docs (year)

23

Docs 3y

106

Total refs

1061

Cites 3y

179

Citable 3y

104

Cites/Doc 2y

1.86

Ref/Doc

46.13

Immediate OA

2040 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients

View more

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge

View more

Current awareness in human psychopharmacology

View more

Current awareness in human psychopharmacology

View more

Current awareness in human psychopharmacology

View more

Current Awareness

View more

Cortisol awakening response and spatial working memory in man: a U-shaped relationship

View more

Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis

View more

Comments on the paper ?The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study?

View more

Combining high and low frequencies in rTMS antidepressive treatment: preliminary results

View more

Combination of ziprasidone and clozapine in treatment-resistant schizophrenia

View more

Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study

View more
SHOW MORE ARTICLES

Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users

View more

A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance

View more

Clinical Handbook of Psychotropic Drugs(13th Edition). Edited by Kalyna Z. Bezchlibuyle-Butler and J. Joel Jeffries. Hogrefe and Huber: USA, 2003. ISBN 0-88937-273-x

View more

Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients

View more

Brain injury and mental retardation: psychopharmacology and neuropsychiatry. C. Thomas Gualtiere. Lippincott Williams and Wilkins: Philadelphia, 2002. Pages: 509. ISBN 0-7817-3473-8

View more

Biochemical Basis of Neuropharmacology(8th Edition). J. R. Cooper, F. E. Bloom and R. H. Roth. Oxford University Press: Oxford, 2002. ISBN 0-19-514007-9

View more

Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study

View more

Animal models of depression: are there any?

View more

Acute glucocorticoid effects on the multicomponent model of working memory

View more

Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions

View more

Acute cholecystokinin effects on event-related potentials in healthy volunteers

View more

Acute and continuation risperidone monotherapy in mania

View more

FAQS